Misconceptions about the Flu Vaccine
The providers of Teverbaugh, Croland & Mueller and Associates are excited to be launching Myriad myRisk genetic cancer screening. Myriad myRisk is the only hereditary cancer test that combines your genetic information with personal and family history to generate guideline-based management options to help you lower your cancer risks. It looks at multiple genes that impact inherited risks for eight important cancers – breast, ovarian, uterine, gastric, colorectal, pancreatic, prostate and melanoma. In families with hereditary cancer, the cancer risk is passed down through generations by inheriting altered genes which increase the risk of developing cancer. People with hereditary cancer are more likely to have relatives with the same type or related type of cancer. They may develop more than one cancer and their cancer often occurs at an earlier age. A simple blood test can identify gene mutations which could impact lifetime medical management. Our office has combined with Myriad to offer this screen service to our patients who meet cancer screening criteria. Myriad has over 25 years of experience and more than 1.6 million people tested and is the established leader in the field of genetic testing. Our team comprised of Jennifer Lynch, C.N.M., Megan Nestrud, W.H.N.P., and Lisa Vrchota, Nurse Navigator, invite you to answer a few simple questions to see if you meet the cancer risk criteria for Myriad screening. Call our office at (309) 692-2025 for more information.
You Might Also Enjoy...
Feel free to email us regarding any scheduling or general questions!